Improving Outcomes After Gastroesophageal Cancer Resection Can Japanese Results Be Reproduced in Western Centers?

被引:26
作者
Hanna, George B. [1 ]
Boshier, Piers R. [1 ]
Knaggs, Alison [2 ]
Goldin, Robert [3 ]
Sasako, Mitsuru [4 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, London W2 1NY, England
[2] Univ London Imperial Coll Sci Technol & Med, Dept Anaesthesia, London W2 1NY, England
[3] Univ London Imperial Coll Sci Technol & Med, Ctr Pathol, London W2 1NY, England
[4] Hyogo Coll Med, Dept Surg, Nishinomiya, Hyogo 6638501, Japan
关键词
GASTRIC-CANCER; NODAL DISSECTION; UNITED-STATES; SURVIVAL; SURGERY; MORTALITY; LYMPHADENECTOMY; ESOPHAGECTOMY; GASTRECTOMY; CARCINOMA;
D O I
10.1001/archsurg.2012.983
中图分类号
R61 [外科手术学];
学科分类号
摘要
Hypothesis: Extended lymphadenectomy in gastroesphageal cancer leads to improved long-term survival without compromising postoperative outcomes in Western patients to attain the standard achieved in Japanese centers. Design: Cohort study comparing postoperative outcomes and long-term survival with data from the National Cancer Center (NCC) of Tokyo, Japan. Outcomes were also compared with data from the UK National Oesophago-Gastric Cancer Audit (NOGCA) and a representative cohort from southeast England. Prospectively collected data were independently audited. Setting: University medical center. Patients: From 2003 to 2010, 100 patients underwent gastrectomy and 109 underwent esophagectomy. Main Outcome Measures: Postoperative mortality and morbidity and long-term overall survival. Lymph node count was used as a measure for the extent of lymphad-enectomy. Results: One death occurred after esophagectomy and none after gastrectomy. Anastomotic leak rate was approximately 2% in both cohorts. Kaplan-Meier estimates of 5-year overall survival after gastrectomy and esophagectomy were 58.4% and 47.8%, respectively. Postoperative mortality and technical complications for gastric and esophageal cancer resections were similar to NCC rates (P=. 20). Stage for stage 5-year survival rates in patients with esophageal cancer and stages II and III gastric cancer were similar to outcomes in the NCC. The 5-year survival for patients with gastric cancer was worse for those with stage I (P < .001) and better for those with stage IV (P < .001) disease compared with NCC rates. Postoperative outcomes and long-term survival were significantly better than those reported by the NOGCA and the data from the southeast of England (P < .05). Conclusions: This study demonstrates that postoperative outcomes and long-term survival after gastroesophageal cancer resection can be improved in Western patients to the highest standard achieved in Japan.
引用
收藏
页码:738 / 745
页数:8
相关论文
共 35 条
[1]  
Allum WH, 2002, GUT, V50, P1
[2]   Hospital volume and survival in oesophagectomy and gastrectomy for cancer [J].
Anderson, Oliver ;
Ni, Zhifang ;
Moller, Henrik ;
Coupland, Victoria H. ;
Davies, Elizabeth A. ;
Allum, William H. ;
Hanna, George B. .
EUROPEAN JOURNAL OF CANCER, 2011, 47 (16) :2408-2414
[3]  
[Anonymous], 1998, GASTRIC CANCER, V1, P10
[4]  
Bancewicz J, 2002, LANCET, V359, P1727
[5]  
BOLLSCHWEILER E, 1993, CANCER-AM CANCER SOC, V71, P2918, DOI 10.1002/1097-0142(19930515)71:10<2918::AID-CNCR2820711006>3.0.CO
[6]  
2-V
[7]   Extended lymph-node dissection for gastric cancer [J].
Bonenkamp, JJ ;
Hermans, J ;
Sasako, M ;
van de Velde, CJH .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (12) :908-914
[8]   Transthoracic Versus Transhiatal Esophagectomy for the Treatment of Esophagogastric Cancer A Meta-Analysis [J].
Boshier, Piers R. ;
Anderson, Oliver ;
Hanna, George B. .
ANNALS OF SURGERY, 2011, 254 (06) :894-906
[9]   Subtotal versus total gastrectomy for gastric cancer -: Five-year survival rates in a multicenter randomized Italian trial [J].
Bozzetti, F ;
Marubini, E ;
Bonfanti, G ;
Miceli, R ;
Piano, C ;
Gennari, L .
ANNALS OF SURGERY, 1999, 230 (02) :170-178
[10]   EVALUATION OF THE EXTENT OF LYMPHADENECTOMY IN A RANDOMIZED TRIAL OF WESTERN-TYPE VERSUS JAPANESE-TYPE SURGERY IN GASTRIC-CANCER [J].
BUNT, AMG ;
HERMANS, J ;
BOON, MC ;
VANDEVELDE, CJH ;
SASAKO, M ;
FLEUREN, GJ ;
BRUIJN, JA .
JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (02) :417-422